KYTX Competitors & Alternatives
Compare Kyverna Therapeutics, Inc. Common Stock with similar stocks in the same industry
Biotechnology
KYTX
Main Stock$7.77
Tradestie Score
46
Market Cap
$258.18M
Analyst Upside
+291.2%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CTMX
CytomX Therapeutics, Inc.
|
$3.70
|
$552.46M | - | 59 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$14.71
|
$540.97M | - | 62 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$13.18
|
$529.35M | 6.6 | 48 | Compare |
|
MNPR
Monopar Therapeutics Inc. Common Stock
|
$103.33
|
$522.78M | - | 54 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.17
|
$512.39M | - | 55 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$41.30
|
$505.12M | 2.2 | 62 | Compare |
|
RGNX
REGENXBIO Inc.
|
$12.75
|
$493.52M | - | 62 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$92.17
|
$492.21M | - | 56 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 56 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$10.21
|
$468.01M | - | 54 | Compare |
More KYTX Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry